The Indian Journal of Chest Diseases and Allied Sciences

Register      Login

VOLUME 59 , ISSUE 1 ( January-March, 2017 ) > List of Articles

Original Article

Prevalence of Tuberculosis Among Bronchial Asthma Patients Treated with Steroids

KV Anees, Mahendra Nagar

Keywords : Bronchial asthma, Corticosteroids, Tuberculosis

Citation Information : Anees K, Nagar M. Prevalence of Tuberculosis Among Bronchial Asthma Patients Treated with Steroids. Indian J Chest Dis Allied Sci 2017; 59 (1):13-15.

DOI: 10.5005/ijcdas-59-1-13

License: CC BY-NC 4.0

Published Online: 18-11-2022

Copyright Statement:  Copyright © 2017; The Author(s).


Background. Bronchial asthma and tuberculosis (TB) are two of the common diseases seen in developing countries, and most of the patients with bronchial asthma require life-long therapy with steroids. Objectives. To estimate the frequency of pulmonary TB among bronchial asthma patients treated with corticosteroids. Methods. Patients with bronchial asthma who have been on steroid therapy were enrolled. Diagnosis of TB was made by history, clinical examination, and laboratory tests findings. Results. Of 100 patients with bronchial asthma, 11 patients developed pulmonary TB (4 sputum-positive, 7 sputumnegative). Of the 60 patients who were on oral steroids, 52 were taking steroids for more than 2 years; of them, 10 (19%) patients developed pulmonary TB. Of the 40 patients who were on inhaled steroids, 80% were using it for more than 2 years; 1 (3.2%) of them developed pulmonary TB. Conclusion. Systemic corticosteroid therapy significantly increases the risk of pulmonary TB in patients with bronchial asthma.

PDF Share
  1. Beasley R, Crane J, Lai CK, Pearce N. Prevalence and etiology of asthma. J Allergy Clin Immunol 2000;105:S466-72.
  2. The Global Burden of Asthma Report, Global Initiative for Asthma (GINA) 2015.
  3. Trehan AP, Ahmed AR. Corticosteroids: a review with emphasis on complication of prolonged systemic therapy. Ann Allergy 1989;62:375-91.
  4. Fine RM. Side effects associated with systemic corticosteroids. Int J Dermatol 1990;29:331-2.
  5. Agarwal PN, Gupta D, Aggarwal AN, Behera D. Incidence of tuberculosis among patients receiving treatment with oral corticosteroids. J Assoc Physicians India 2000;48:881-4.
  6. Sharma SK, Mohan A, Pande JN, Prasad KL, Gupta AK, Khilnani GC. Clinical profile, laboratory characteristics and outcome in miliary tuberculosis. Q J Med 1995;88:29-37.
  7. Lieberman P, Patterson R, Kunske R. Complications of long-term steroid therapy for asthma. J Allergy Clin Immunol 1972;49:329-36.
  8. Dharam Pal, Behera D, Gupta D, Aggarwal A. Tuberculosis in patients receiving prolonged treatment with oral corticosteroids respiratory disorders. Indian J Tuberc 2002;49:83-6.
  9. Lee C-H, Kim K, Hyun MK, Jang EJ, Lee NR, Yim J-J. Use of inhaled corticosteroids and the risk of tuberculosis. Thorax 2013;68:1105-13.
  10. Sasaki Y, Yamagishi F, Yagi T, Yamatani H, Kuroda F, Shoda H. A clinical study in the Collagen disease patients developing pulmonary tuberculosis during corticosteroid administration. Kekkaku 2000;75:569-73.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.